
Sign up to save your podcasts
Or


U.S. officials bet on Novavax to provide a shot that could easily be shipped overseas. But its manufacturing problems have left global distributors without enough shots for poor and middle-income countries. POLITICO's Erin Banco reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By POLITICO4.2
386386 ratings
U.S. officials bet on Novavax to provide a shot that could easily be shipped overseas. But its manufacturing problems have left global distributors without enough shots for poor and middle-income countries. POLITICO's Erin Banco reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices

4,176 Listeners

3,434 Listeners

609 Listeners

604 Listeners

1,526 Listeners

454 Listeners

702 Listeners

723 Listeners

962 Listeners

307 Listeners

110 Listeners

294 Listeners

206 Listeners

5,461 Listeners

2,547 Listeners

137 Listeners

146 Listeners

39 Listeners

716 Listeners

478 Listeners

266 Listeners

151 Listeners

10 Listeners